Associations of Circulating Insulin-Growth Factor-1 With Cognitive Functions and Quality of Life Domains in Ambulatory Young Adults With Cerebral Palsy: A Pilot Study
Open Access
- 27 June 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 13, 748015
- https://doi.org/10.3389/fneur.2022.748015
Abstract
Objective: Adults with cerebral palsy (CP) often have impaired cognitive functions. CP also has deteriorations in multiple quality-of-life (QoL) domains. The bio-psycho-social health psychology model posits that biological factor interacts with social and psychological functions. However, the biological determinant of psycho-social and functional outcomes in CP has been scarcely examined. Circulating Insulin-like growth factor-1 (IGF-1) is associated with cognitive deficits in older adults, we thus aimed to examine the associations of circulating IGF-1 with: (1) objectively measured cognitive functions, (2) self-reported cognitive functions, and (3) QoL measures in adults diagnosed with CP. Methods: Seventy-two adults with CP and varying degrees of cognitive functions were recruited from an accredited clinical motion analysis laboratory at a regional Children's Hospital. Circulating IGF-1 was measured using post-fasting serum. The Wechsler Adult Intelligence Scale (WAIS) tests were administered to assess multiple cognitive functions, whereas the Patient-Reported Outcomes Measurement Information System (PROMIS) was used to measure multiple domains of self-reported health, including cognitive complaints and eight QoL domains. Results: Sixty-eight participants had complete data [mean age = 25 (SD = 5.3), female = 52.8%]. Controlling for covariates, circulating IGF-1 was associated with multiple cognitive domains, including positively with declarative memory and executive function and inversely with visual-spatial and motor skills, and processing speed, while no association with subjective memory complaint was detected. Circulating IGF-1 was also inversely associated with four QoL domains, including depressive symptoms, executive function, physical function, and social roles and activities. Conclusions: In CP, circulating IGF-1 might be a useful biological determinant of objective cognitive functions and several quality-of-life domains commonly impaired in CP.Funding Information
- National Institute on Disability, Independent Living, and Rehabilitation Research (90IF0055-01, H133G130200)
This publication has 66 references indexed in Scilit:
- IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of AtherosclerosisPLOS ONE, 2013
- Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and ControversiesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Aging, Synaptic Dysfunction, and Insulin-Like Growth Factor (IGF)-1The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Effects of recombinant growth hormone (GH) replacement and psychomotor and cognitive stimulation in the neurodevelopment of GH-deficient (GHD) children with cerebral palsy: a pilot studyTherapeutics and Clinical Risk Management, 2011
- Growth hormone deficiency and cerebral palsyTherapeutics and Clinical Risk Management, 2010
- Awareness of Memory Abilities in Community-Dwelling Older Adults with Suspected Dementia and Mild Cognitive ImpairmentDementia and Geriatric Cognitive Disorders, 2010
- Systemic inflammation (Interleukin 6) predicts all-cause mortality in men: results from a 9-year follow-up of the MEMO StudyAGE, 2010
- Evaluation of Item CandidatesMedical Care, 2007
- Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive agingAgeing Research Reviews, 2005
- The Need for a New Medical Model: A Challenge for BiomedicineScience, 1977